Aristeia Capital »

Engene Therapeutics shares owned by Aristeia Capital

Quarter-by-quarter ownership of Engene Therapeutics shares owned by Aristeia Capital from 13F filings

Historical chart of Aristeia Capital investment in Engene Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Engene Therapeutics held by Aristeia Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Engene Therapeutics by Aristeia Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $48k 198k 0.24

More positions owned by Aristeia Capital

Invesco Qqq Trust Series 1 Unit Ser 1 Put Option (QQQ)
State Street Spdr S&p 500 Etf Trust Tr Unit Put Option (SPY)
SM Energy (SM)
Super Micro Computer Note 3.500% 3/0 (Principal)
Strategy Note 12/0 (Principal)
People Com New
Evergy Note 4.500%12/1 (Principal)
Heico Corp Cl A (HEI.A)
Akamai Technologies Note 0.250% 5/1 (Principal)
Guardant Health Debt 1.250% 2/1 (Principal)
Super Micro Computer 7 Dep Cm Sr A Wi
Doordash Note 5/1 (Principal)
Firstenergy Corp Note 3.625% 1/1 (Principal)
Super Micro Computer Note 2.250% 7/1 (Principal)
Strategy Note 3/0 (Principal)

View all positions for Aristeia Capital

Top funds holding Engene Therapeutics

BVF
Blue Owl Capital Holdings
Caption Management
LMR Partners
Aristeia Capital
D. E. Shaw & Co
Millennium Management
Toronto-Dominion Bank
CSS
Intl Fcstone
Clear Street Group

View all funds holding Engene Therapeutics